Table 1.
No. | Excluded Study in the Second Phase | The Reason for Its Exclusion |
---|---|---|
1 | Peng et al. [18] | They were solely based on bioinformatics. |
2 | Qattan et al. [19] | |
3 | Liu et al. [20] | |
4 | Naba et al. [21] | The PD-L1-inhibiting miRs were not adequately investigated. |
5 | Yang et al. [22] | |
6 | Noman et al. [23] | |
7 | Zhang et al. [24] | |
8 | Nafea et al. [25] | |
9 | Youness et al. [26] | |
10 | Hamed et al. [27] | Pro-PD-L1 miR was studied. |
11 | Yao et al. [28] | The cross-talk between miR and PD-L1 in macrophages was studied. |
12 | Rogers, 2018 [29] | The cross-talk between miR and PD-L1 was evaluated only in murine TNBC. |
Abbreviations: TNBC: triple-negative breast cancer, and PD-L1: programmed death-ligand 1.